Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding-Reference-Cited by-同舟云学术

Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major Bleeding

Published:2023-10-26 Issue:11 Volume:43 Page:883-888
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Sheikh-Taha Marwan^ORCID,Clark Holly L.,Crawley R. Monroe

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-023-01316-0.pdf

Reference22 articles.

1. Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128(12):1300–5.

2. Ho KH, van Hove M, Leng G. Trends in anticoagulant prescribing: a review of local policies in English primary care. BMC Health Serv Res. 2020;20(1):1–8.

3. Prescribing information—FEIBA. https://www.shirecontent.com/PI/PDFs/FEIBA_USA_ENG.pdf. Accessed 1 Aug 2022.

4. Milling TJ, Pollack CV. A review of guidelines on anticoagulation reversal across different clinical scenarios–Is there a general consensus? Am J Emerg Med. 2020;38(9):1890–903.

5. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients. J Thromb Haemostasis. 2005;3(4):692–4.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apixaban/factor-VIII-inhibitor-bypassing-fraction/rivaroxaban;Reactions Weekly;2024-02-03